NeurosciencebioRxivPreprint
In vivo Proximity & Spatial Proteomics with CRISPR Screening Identify STXBP1 as a Protective Modifier of a-synuclein Toxicity in Dopamine Neurons.
Daichi Shonai, Julie K. Kent, Arinze Emmanuel Okafor…·Scott H. Soderling
The paper uses in vivo proteomics and CRISPR screening to identify STXBP1 as a protective factor against α-synuclein toxicity in dopamine neurons in Parkinson's disease models.
2 citations